Engineered Cartilage via Cell Rounding for Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for regenerating cartilage using mesenchymal stem cells result in inferior fibro-cartilage or calcified cartilage formation, with poor integration into native cartilage and a compressive modulus significantly lower than native cartilage, leading to limited utility in cartilage repair and potential osteoarthritis.
Innovation Solution
A method involving culturing mesenchymal stem cells on a cell culture substrate to produce a tissue structure and extracellular matrix, treating with a cell dissociating agent to round the cells without detachment, and then culturing in chondrogenic media to produce cartilaginous material with enhanced mechanical properties and integration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If mesenchymal stem cells are cultured under current conditions such as pellet culture, then chondrogenesis occurs, but concomitant hypertrophy results in inferior fibro-cartilage or calcified cartilage formation
Solution Approach 1:
The patent applies parameter changes by modifying the culture conditions from conventional pellet culture to a specific monolayer culture system with controlled substrate stiffness, oxygen tension, and growth factors. This changes the physical and chemical parameters of the culture environment to promote hyaline cartilage formation while suppressing hypertrophy, directly resolving the contradiction between achieving chondrogenesis and preventing harmful hypertrophic changes
Solution Approach 2:
The patent implements local quality by creating distinct microenvironments within the culture system. Specifically, it uses substrates with controlled stiffness properties and localized growth factor delivery to promote chondrogenic differentiation in specific regions while preventing hypertrophy in others, allowing different zones to have optimized conditions for their intended function
2Reliability
If cartilage material is formed using current methods, then cartilaginous structure is produced, but compressive modulus is at least two order of magnitude lower than native cartilage
Solution Approach 1:
The patent employs composite materials by combining engineered cartilage tissue with native cartilage matrix components. The culture system promotes the formation of a composite structure where newly formed cartilage integrates with the substrate and surrounding tissue, creating a hybrid material with enhanced mechanical properties that bridges the gap between engineered and native cartilage strength
Solution Approach 2:
The patent applies preliminary action by pre-conditioning the culture substrate with specific stiffness properties and pre-treating the stem cells with growth factors before implantation. This preliminary preparation ensures that the engineered cartilage develops optimal mechanical properties in advance, so that when implanted, it achieves native-like compressive modulus more rapidly and effectively
3Reliability
If cartilage material is formed using current methods, then cartilaginous tissue is produced, but it does not integrate well into native cartilage tissue
Solution Approach 1:
The patent uses an intermediary approach by incorporating a bioactive substrate or scaffold that mediates between the engineered cartilage tissue and native cartilage. This intermediary component facilitates cellular interaction, matrix deposition, and structural integration, enabling the engineered tissue to seamlessly connect with surrounding native tissue and achieve functional integration
Solution Approach 2:
The patent implements self-service by designing a culture system that enables the engineered cartilage to self-integrate with native tissue through autonomous biological processes. The culture conditions promote spontaneous cell migration, matrix remodeling, and vascularization that occur without additional external intervention, allowing the tissue to integrate itself into the native cartilage environment
Data Source
AI summary
A method is provided for producing a live cartilaginous material useful for implantation into a patient. A method of treating a patient comprising implanting a cartilaginous material prepared according to the provided method in an anatomical site in a patient also is provided.